Global Business Summit 2025 में Dilip Shanghvi और Naveen Jindal के साथ खास चर्चा में Nikunj Dalmia!

Quite noisy tariffs, supply chains, global growth, rupee, dollar, manufacturing, a lot is at play. So how is the world evolving? I know I am on your left side but that's not the wrong side. But is India on the wrong side of what is happening to global tariffs given that requirement for the US government which is to control the health care cost in the US?

Good evening everyone. So many of you would be surprised to know that these tariffs from us actually is just not now. 25%, then many products they're more than 200%. Produce steel for domestic consumption. We are growing, we are a growing economy, we are growing at a very fast rate, much faster than USA or any other country. So our demand is mostly for domestic consumption. Then maybe it may work to our benefit, in fact. But are Indian steel companies globally comparative? Because the view, at least in the stock markets and those, there's hardly any protection that Indian steel industry has. But obviously, with this, all the countries that were exporting to USA, they might start wanting to dump in India. The Commerce Ministry to put countering duty to, I mean, duty on all imports from every country. So I'll come to what India should do, but I'll just turn of our viewers who would be watching this show. Sun Pharma is India's largest Pharma company. Sun Pharma is India's largest Pharma exporter. Sun Pharma has the largest market share in the Branded Market, moved up the value chain from oral and generic, then to complex and now to specialized. Where do you see the Indian Pharma sector moving, evolving, and expanding? Or five tablets out of 10 consumed in the US are produced or linked with the Indian API, so that's a remarkable achievement in a relatively short period.

Products developed in India, so if some of them becomes globally, almost 5 years to convince Mr. Shanghvi to come for an interaction. So I've got a lot of questions, I hope you're ready, sir.